Business Context and Reporting Period
Company: Inmune Bio, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 10, 2025
Reporting Period: Single event date (February 10, 2025)
Context: The filing serves as a Regulation FD disclosure to make available investor and webinar presentation materials to the public.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of non-financial presentation materials and does not contain audited or unaudited financial statements.
Material Changes
No material financial changes or operational events are reported in this filing. The sole material action is the release of the "Investor Presentation" and "Webinar Presentation" as Exhibits 99.1 and 99.2.
Guidance, Outlook, and Risks
Management Commentary: The Company intends to use the attached slide decks for investor and webinar presentations from time to time.
Legal Disclaimer: The information contained in the presentations and this Item 7.01 is furnished and shall not be deemed "filed" under Section 18 of the Exchange Act. It is not subject to the liabilities of that section and shall not be incorporated by reference into any other filings under the Securities Act or Exchange Act.
Risks: No specific risks or contingencies are detailed in this filing text.
Investor Verification Checklist
- Verify the content of the "Investor Presentation" (Exhibit 99.1) and "Webinar Presentation" (Exhibit 99.2) available on the Company's website.
- Confirm that the presentations contain forward-looking statements and review associated risk factors within those documents.
- Note that the data in the presentations is not legally "filed" with the SEC and carries different liability standards than the 8-K itself.
- Check the Company's website (https://inmunebio.com/index.php/investors/corporate-presentation) for the actual slide decks referenced.